Leukemias - Principles and Practice of Therapy (Hardcover, New)

Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials. Topics include: * Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors) * Ras inhibitors * Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors) * Lenalidomide analogs * New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine * Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib) * New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40) * Thrombopoietic agents Leukemias: Principles and Practice of Therapy * Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease * Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area

General

Imprint:	Wiley-Blackwell (an imprint of John Wiley & Sons Ltd)
Country of origin:	United Kingdom
Release date:	November 2010
First published:	December 2010
Authors:	S Faderl
Dimensions:	286 x 222 x 26mm (L x W x T)
Format:	Hardcover
Pages:	456
Edition:	New
ISBN-13:	978-1-4051-8235-5
Categories:	Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology Books > Medicine > Other branches of medicine > Medical imaging > General
LSN:	1-4051-8235-0
Barcode:	9781405182355

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!